Epilepsy News

Although ankylosing spondylitis correlates with higher rates of Alzheimer’s disease, patients who receive TNF inhibitors are less likely to develop the neurologic disorder, according to data published in Pharmacological Research.

Levetiracetam was safe and may be effective in preventing acute seizures in patients with spontaneous intracerebral hemorrhage, according to clinical trial results in The Lancet Neurology.

Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status epilepticus in adults.

A deep-learning model has the potential to predict an individual’s response to antiseizure medications and may inform treatment selection in patients with newly diagnosed epilepsy, researchers reported in JAMA Neurology.

Mortality rates were significantly higher among veterans with drug-resistant epilepsy compared with other veterans and the general United States population, researchers reported in JAMA Neurology.

Researchers at Aston University in England have received funding to explore new methods of recording electrical signals emitted from brain cells, which could lead to potential treatment for conditions like epilepsy and schizophrenia.

In this edition, leisure activities may lower risk for Alzheimer's disease and dementia; most common long COVID symptoms include fatigue and headache; ‘life-changing’ app-based digital therapeutic for tinnitus and more.

Pregnant women with epilepsy had higher rates of depressive and anxiety symptoms during and after pregnancy compared with women who were pregnant only or had epilepsy only, according to data published in Neurology.

An artificial intelligence-based algorithm was able to provide reports of brain abnormalities in cases of drug-resistant focal cortical dysplasia, a leading cause of epilepsy, researchers reported in Brain.

In this week’s edition, a Labcorp blood test identifies signs of neurodegenerative disease; the FDA approves an oral treatment for partial seizures in teens; ketamine shows efficacy in epilepsy; and more.